LEVI-04 Shows Promise as a Novel Non-Opioid Therapy for Knee Osteoarthritis in Phase 2 Trial
A recent study shared by The Lancet shows that a first-in-class investigational therapy targeting neurotrophin-3 (NT-3) significantly reduced pain and improved function in patients with knee osteoarthritis (OA), according to…